131 related articles for article (PubMed ID: 1528397)
1. Effect of phencyclidine on spontaneous and N-methyl-D-aspartate (NMDA)-induced efflux of dopamine from superfused slices of rat striatum.
Ohmori T; Koyama T; Nakamura F; Wang P; Yamashita I
Neuropharmacology; 1992 May; 31(5):461-7. PubMed ID: 1528397
[TBL] [Abstract][Full Text] [Related]
2. [A study on the pharmacological action of phencyclidine].
Ohmori T
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):205-13. PubMed ID: 8099562
[TBL] [Abstract][Full Text] [Related]
3. The effect of phencyclidine and DL-2-amino-5-phosphonovaleric acid on N-methyl-D-aspartic acid induced changes in extracellular concentration of dopamine and DOPAC in the rat neostriatum.
Marek P; Chapman CD; Howard S
Neuropharmacology; 1992 Feb; 31(2):123-7. PubMed ID: 1348111
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
5. Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure.
Ali SF; Holson RR; Newport GD; Slikker W; Bowyer JF
Brain Res Dev Brain Res; 1993 May; 73(1):25-33. PubMed ID: 7685665
[TBL] [Abstract][Full Text] [Related]
6. Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.
Snell LD; Johnson KM; Yi SJ; Lessor RA; Rice KC; Jacobson AE
Life Sci; 1987 Dec; 41(24):2645-54. PubMed ID: 2826948
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.
Nishijima K; Kashiwa A; Hashimoto A; Iwama H; Umino A; Nishikawa T
Synapse; 1996 Apr; 22(4):304-12. PubMed ID: 8867025
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
[TBL] [Abstract][Full Text] [Related]
10. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
[TBL] [Abstract][Full Text] [Related]
11. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
Vickroy TW; Johnson KM
J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
[TBL] [Abstract][Full Text] [Related]
12. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
13. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
14. Phencyclidine-induced desensitization of striatal dopamine release.
Dwoskin LP; Jewell AL; Buxton ST; Carney JM
Neuropharmacology; 1992 Oct; 31(10):1033-9. PubMed ID: 1436385
[TBL] [Abstract][Full Text] [Related]
15. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
Jones SM; Snell LD; Johnson KM
J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens.
Jones SM; Snell LD; Johnson KM
Neuropharmacology; 1987; 26(2-3):173-9. PubMed ID: 2884587
[TBL] [Abstract][Full Text] [Related]
17. Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenylacetic acid and homovanillic acid in conscious and anesthetized rats.
Chapman CD; Gazzara RA; Howard SG
Neuropharmacology; 1990 Apr; 29(4):319-25. PubMed ID: 2342635
[TBL] [Abstract][Full Text] [Related]
18. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo.
Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL
Life Sci; 1989; 45(12):1065-72. PubMed ID: 2796597
[TBL] [Abstract][Full Text] [Related]
20. The effect of phencyclidine on dopamine synthesis and metabolic in rat striatum.
Doherty JD; Simonovic M; So R; Meltzer HY
Eur J Pharmacol; 1980 Jul; 65(2-3):139-49. PubMed ID: 7398783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
